Evidence map›Paper›PMID 36589536›Full record

ReviewFrontiers in aging neuroscience2022

An update on the use of gamma (multi)sensory stimulation for Alzheimer's disease treatment.

Valerio Manippa, Annalisa Palmisano, Marco Filardi, Davide Vilella, Michael A Nitsche, Davide Rivolta, Giancarlo Logroscino

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Frontiers in aging neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06322524 (Shanxi Key Laboratory of Artificial Intelligence Assisted Diagnosis and Treatment for Mental Disorder), which is not on this map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06322524 completednot on this map

Shanxi Key Laboratory of Artificial Intelligence Assisted Diagnosis and Treatment for Mental Disorder

TypeobservationalSponsorThe First Affiliated Hospital of Shanxi Medical UniversityRan2021 to 2022Enrolled37ConditionsSleep Quality, Sleep Duration, Sleep Onset LatencyArmsGamma sensory flicker
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Valerio ManippaDepartment of Education, Psychology and Communication, University of Bari Aldo Moro, Bari, Italy.
Annalisa PalmisanoDepartment of Education, Psychology and Communication, University of Bari Aldo Moro, Bari, Italy.
Marco FilardiDepartment of Basic Medicine, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
Davide VilellaCenter for Neurodegenerative Diseases and the Aging Brain, University of Bari Aldo Moro at Pia Fondazione "Card. G. Panico", Tricase, Italy.
Michael A NitscheDepartment of Psychology and Neurosciences, Leibniz Research Centre for Working Environment and Human Factors, Dortmund, Germany.
Davide RivoltaDepartment of Education, Psychology and Communication, University of Bari Aldo Moro, Bari, Italy.
Giancarlo LogroscinoDepartment of Basic Medicine, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
University of Bari Aldo Moro · ITEvangelisches Krankenhaus Bielefeld · DETU Dortmund University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is characterized by reduced fast brain oscillations in the gamma band (γ, > 30 Hz). Several animal studies show that inducing gamma oscillations through (multi)sensory stimulation at 40 Hz has the potential to impact AD-related cognitive decline and neuropathological processes, including amyloid plaques deposition, neurofibrillary tangles formation, and neuronal and synaptic loss. Therefore Gamma Entrainment Using Sensory stimulation (GENUS) is among the most promising approaches for AD patients' treatment. This review summarizes the evidence on GENUS effectiveness, from animal models to AD patients. Despite the application on human is in its infancy, the available findings suggest its feasibility for the treatment of AD. We discuss such results in light of parameter improvement and possible underlying mechanisms. We finally emphasize the need for further research for its development as a disease-modifying non-pharmacological intervention.

Indexed as

40 Hz stimulationdementiagamma wavesmulti-sensory therapyneuromodulationnon-invasive brain stimulation

Identifiers

PMID36589536
PMCPMC9797689
OpenAlexW4311506390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.